Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for breast implant-associated anaplastic large cell lymphoma has been reported in the published literature.
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
109 publications have been identified in PubMed for breast implant-associated anaplastic large cell lymphoma. Research spans Review / Meta-Analysis (28%), Case Report / Case Series (18%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 30 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
European rare disease database
Patient case studies | 20 | 18% |
Disease patterns and progression | 15 | 14% |
Other research | 12 | 11% |
Clinical study results | 12 | 11% |
Laboratory research | 10 | 9% |
Testing and diagnosis research | 9 | 8% |
New treatment approaches | 1 | 1% |
Yanay N (2026). [PMID: 41903369](https://pubmed.ncbi.nlm.nih.gov/41903369/). *Maturitas*. [Review / Meta-Analysis]
Abbott EN (2026). [PMID: 41687071](https://pubmed.ncbi.nlm.nih.gov/41687071/). *Ann Plast Surg*. [Review / Meta-Analysis]
Maerten T (2026). [PMID: 41659022](https://pubmed.ncbi.nlm.nih.gov/41659022/). *Case Rep Hematol*. [Case Report / Case Series]
Valente DS (2026). [PMID: 42170574](https://pubmed.ncbi.nlm.nih.gov/42170574/). *Transl Breast Cancer Res*. [Review / Meta-Analysis]
Kalstrup J (2026). [PMID: 42090861](https://pubmed.ncbi.nlm.nih.gov/42090861/). *Breast*. [Epidemiology / Natural History]
Jacobi M (2026). [PMID: 42172927](https://pubmed.ncbi.nlm.nih.gov/42172927/). *J Plast Reconstr Aesthet Surg*. [Epidemiology / Natural History]
Nguyen TD (2026). [PMID: 41081820](https://pubmed.ncbi.nlm.nih.gov/41081820/). *Aesthetic Plast Surg*. [Diagnostic / Biomarker]
Huang HH (2026). [PMID: 41576253](https://pubmed.ncbi.nlm.nih.gov/41576253/). *Ann Plast Surg*. [Review / Meta-Analysis]
Bosc R (2026). [PMID: 41620260](https://pubmed.ncbi.nlm.nih.gov/41620260/). *Ann Chir Plast Esthet*. [Review / Meta-Analysis]
Eisenberg TS (2026). [PMID: 41023230](https://pubmed.ncbi.nlm.nih.gov/41023230/). *Aesthetic Plast Surg*. [Case Report / Case Series]
AI-curated news mentioning breast implant-associated anaplastic large cell lymphoma
Updated Sep 16, 2026
A recent survey by the European Society of Plastic, Reconstructive and Aesthetic Surgery highlights current reporting, surveillance, and management practices for breast implant-associated anaplastic large cell lymphoma. This study provides valuable insights into the landscape of this rare disease in Europe.
Recent research highlights breast implant-associated anaplastic large cell lymphoma as a heterogeneous T cell disease characterized by active pro-tumor cross-talk and immune suppression. This study provides insights into the disease's complexity, which may inform future therapeutic strategies.
A case report highlights the occurrence of breast implant-associated anaplastic large cell lymphoma following prophylactic mastectomy and breast reconstruction. This finding underscores the potential risks associated with breast implants, warranting further investigation.